BioVie (BIVI)
(Delayed Data from NSDQ)
$2.76 USD
-0.07 (-2.47%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $2.75 -0.01 (-0.36%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for BioVie Inc falls in the month of June.
All items in Millions except Per Share data.
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 34 | 19 | 5 | 0 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 0 | 0 | 0 | 0 |
Total Current Assets | NA | 34 | 19 | 5 | 0 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1 | 1 | 1 | 2 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 35 | 20 | 6 | 2 |
Liabilities & Shareholders Equity | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 |
---|---|---|---|---|---|
Notes Payable | NA | 9 | 0 | 0 | 0 |
Accounts Payable | NA | 3 | 2 | 1 | 1 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 1 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 2 | 2 | 0 | 21 |
Total Current Liabilities | NA | 14 | 4 | 1 | 24 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 5 | 12 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 20 | 16 | 1 | 24 |
Shareholders Equity | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 316 | 255 | 230 | 20 |
Retained Earnings | NA | -301 | -251 | -225 | -41 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 15 | 4 | 5 | -22 |
Total Liabilities & Shareholder's Equity | NA | 35 | 20 | 6 | 2 |
Total Common Equity | 0 | 15 | 4 | 5 | -22 |
Shares Outstanding | 6.10 | 3.60 | 2.40 | 1.40 | 1.30 |
Book Value Per Share | 0.00 | 4.26 | 1.53 | 3.61 | -16.54 |
Fiscal Year End for BioVie Inc falls in the month of June.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 30 | 20 | 21 | 34 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 0 | 0 | 2 | 0 |
Total Current Assets | NA | 31 | 21 | 23 | 34 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 1 | 1 | 1 | 1 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 32 | 21 | 24 | 35 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 8 | 10 | 9 | 9 |
Accounts Payable | NA | 4 | 4 | 3 | 3 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 1 | 2 |
Total Current Liabilities | NA | 12 | 14 | 13 | 14 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 3 | 5 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 13 | 14 | 16 | 20 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 348 | 328 | 319 | 316 |
Retained Earnings | NA | -329 | -320 | -312 | -301 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 19 | 7 | 8 | 15 |
Total Liabilities & Shareholder's Equity | NA | 32 | 21 | 24 | 35 |
Total Common Equity | 0 | 19 | 7 | 8 | 15 |
Shares Outstanding | 6.10 | 6.10 | 3.70 | 3.60 | 3.60 |
Book Value Per Share | 0.00 | 3.10 | 2.02 | 2.10 | 4.26 |